193 related articles for article (PubMed ID: 18191514)
1. [In vitro activity of ertapenem against strains isolated from diabetic foot infections].
Sotto A; Lemaire X; Jourdan N; Bouziges N; Richard JL; Lavigne JP
Med Mal Infect; 2008 Mar; 38(3):146-52. PubMed ID: 18191514
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers.
Sotto A; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2007 Nov; 55(8-9):398-406. PubMed ID: 17905534
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of daptomycin against strains isolated from diabetic foot ulcers].
Sotto A; Laouini D; Bouziges N; Jourdan N; Richard JL; Lavigne JP
Pathol Biol (Paris); 2010 Feb; 58(1):73-7. PubMed ID: 19875242
[TBL] [Abstract][Full Text] [Related]
4. Comparative antimicrobial susceptibility of aerobic and facultative bacteria from community-acquired bacteremia to ertapenem in Taiwan.
Lee SC; Huang SS; Lee CW; Fung CP; Lee N; Shieh WB; Siu LK
BMC Infect Dis; 2007 Jul; 7():79. PubMed ID: 17640342
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activities of ertapenem against aerobic and facultative bacterial pathogens from patients with complicated skin and skin structure infections.
Pelak BA; Bartizal K; Woods GL; Gesser RM; Motyl M
Diagn Microbiol Infect Dis; 2002 Jun; 43(2):129-33. PubMed ID: 12088620
[TBL] [Abstract][Full Text] [Related]
6. Microbiologic characteristics and antibiotic resistance rates of diabetic foot infections.
Pontes DG; Silva ITDCE; Fernandes JJ; Monteiro AFG; Gomes PHDS; Ferreira MGM; Lima FG; Correia JO; Santos NJND; Cavalcante LP
Rev Col Bras Cir; 2020; 47():e20202471. PubMed ID: 32667581
[TBL] [Abstract][Full Text] [Related]
7. Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcers.
Turhan V; Mutluoglu M; Acar A; Hatipoğlu M; Önem Y; Uzun G; Ay H; Öncül O; Görenek L
J Infect Dev Ctries; 2013 Oct; 7(10):707-12. PubMed ID: 24129622
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal activity of ertapenem against major intra-abdominal pathogens.
Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S
Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463
[TBL] [Abstract][Full Text] [Related]
9. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections.
Hicks PS; Pelak B; Woods GL; Bartizal KF; Motyl M
Clin Microbiol Infect; 2002 Nov; 8(11):753-7. PubMed ID: 12445016
[TBL] [Abstract][Full Text] [Related]
11. In vitro spectrum of pexiganan activity when tested against pathogens from diabetic foot infections and with selected resistance mechanisms.
Flamm RK; Rhomberg PR; Simpson KM; Farrell DJ; Sader HS; Jones RN
Antimicrob Agents Chemother; 2015 Mar; 59(3):1751-4. PubMed ID: 25583717
[TBL] [Abstract][Full Text] [Related]
12. Antibacterial effect of NSAIDS on clinical isolates of urinary tract infection and diabetic foot infection.
Akhter T; Baqai R; Aziz M
Pak J Pharm Sci; 2010 Jan; 23(1):108-13. PubMed ID: 20067876
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
Vega S; Dowzicky MJ
Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
[TBL] [Abstract][Full Text] [Related]
16. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul.
Tariq TM
J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929
[TBL] [Abstract][Full Text] [Related]
17. Microbiology of diabetic foot infections in a teaching hospital in Malaysia: a retrospective study of 194 cases.
Raja NS
J Microbiol Immunol Infect; 2007 Feb; 40(1):39-44. PubMed ID: 17332905
[TBL] [Abstract][Full Text] [Related]
18. [Clinical distribution and antimicrobial resistance analysis of 754 pathogenic bacteria in diabetic foot infection].
Shen Q; Lin D; Zhu H; Ge S; Wu W; Pan X; Gu X; Gu X; Shen F
Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(12):889-94. PubMed ID: 24854906
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Jones RN; Sader HS; Fritsche TR; Pottumarthy S
Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
[TBL] [Abstract][Full Text] [Related]
20. Microbiological profile and clinical characteristics of diabetic foot infection in northern China: a retrospective multicentre survey in the Beijing area.
Li X; Qi X; Yuan G; Ju S; Yu Z; Deng W; Liu Y; Li Y; Bu X; Ding M; Li Q; Guo X
J Med Microbiol; 2018 Feb; 67(2):160-168. PubMed ID: 29293083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
